1 - 25 of 26 results for author:"Nicosia S.V." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cells. Wang L., Xiang S., Williams K.A., Dong H., Bai W., Nicosia S.V., Khochbin S., Bepler G., Zhang X. PLoS ONE 7:e44265-e44265(2012) · Mapped (16) |
| MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. Xu C.X., Xu M., Tan L., Yang H., Permuth-Wey J., Kruk P.A., Wenham R.M., Nicosia S.V., Lancaster J.M., Sellers T.A. et al. J. Biol. Chem. 287:34970-34978(2012) · Mapped (35) |
| Expression of thyroid transcription factor-1 in malignant pleural effusions. Khoor A., Byrd-Gloster A.L., Nicosia S.V. Pathol. Oncol. Res. 17:263-267(2011) · Mapped (3) |
| Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Guo J.P., Shu S.K., He L., Lee Y.C., Kruk P.A., Grenman S., Nicosia S.V., Mor G., Schell M.J., Coppola D. et al. Am. J. Pathol. 175:324-333(2009) · Mapped (1) |
| MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. Fu W., Ma Q., Chen L., Li P., Zhang M., Ramamoorthy S., Nawaz Z., Shimojima T., Wang H., Yang Y. et al. J. Biol. Chem. 284:13987-14000(2009) · Mapped (61) |
| Deacetylation of cortactin by SIRT1 promotes cell migration. Zhang Y., Zhang M., Dong H., Yong S., Li X., Olashaw N., Kruk P.A., Cheng J.Q., Bai W., Chen J. et al. Oncogene 28:445-460(2009) · Mapped (6) |
| MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Yang H., Kong W., He L., Zhao J.J., O'Donnell J.D., Wang J., Wenham R.M., Coppola D., Kruk P.A., Nicosia S.V. et al. Cancer Res. 68:425-433(2008) · Mapped (8) |
| SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Yang Y., Fu W., Chen J., Olashaw N., Zhang X., Nicosia S.V., Bhalla K., Bai W. Nat. Cell Biol. 9:1253-1262(2007) · Mapped (6) |
| Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212. Yang L., Sun M., Sun X.M., Cheng G.Z., Nicosia S.V., Cheng J.Q. J. Biol. Chem. 282:10981-10987(2007) · Mapped (6) |
| Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein. Lee H., Kim D., Dan H.C., Wu E.L., Gritsko T.M., Cao C., Nicosia S.V., Golemis E.A., Liu W., Coppola D. et al. Mol. Cell. Biol. 27:2103-2119(2007) · Mapped (14) |
| Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Bao J., Cao C., Zhang X., Jiang F., Nicosia S.V., Bai W. Mol. Cell. Biol. 27:1321-1333(2007) · Mapped (68) |
| Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Yang H., He L., Kruk P., Nicosia S.V., Cheng J.Q. Int. J. Cancer 119:2304-2312(2006) · Mapped (3) |
| Molecular cloning and characterization of the human AKT1 promoter uncovers its up-regulation by the Src/Stat3 pathway. Park S., Kim D., Kaneko S., Szewczyk K.M., Nicosia S.V., Yu H., Jove R., Cheng J.Q. J. Biol. Chem. 280:38932-38941(2005) · Mapped (19) |
| ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survival. Yuan Z.-Q., Kim D., Kaneko S., Sussman M., Bokoch G.M., Kruh G.D., Nicosia S.V., Testa J.R., Cheng J.Q. J. Biol. Chem. 280:21483-21490(2005) · UniProtKB (1) · Mapped (19) |
| Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. Yang Y., Hou H., Haller E.M., Nicosia S.V., Bai W. |
| Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. Liu Q., Kaneko S., Yang L., Feldman R.I., Nicosia S.V., Chen J., Cheng J.Q. J. Biol. Chem. 279:52175-52182(2004) · Mapped (36) |
| Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Yang H., Ou C.C., Feldman R.I., Nicosia S.V., Kruk P.A., Cheng J.Q. Cancer Res. 64:463-467(2004) · Mapped (10) |
| Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). Dan H.C., Sun M., Kaneko S., Feldman R.I., Nicosia S.V., Wang H.-G., Tsang B.K., Cheng J.Q. J. Biol. Chem. 279:5405-5412(2004) · UniProtKB (1) · Mapped (6) |
| New potential regulators of uterine leiomyomata from DNA arrays: the ionotropic glutamate receptor GluR2. Tsibris J.C., Maas S., Segars J.H., Nicosia S.V., Enkemann S.A., O'Brien W.F., Spellacy W.N. Biochem. Biophys. Res. Commun. 312:249-254(2003) · Mapped (14) |
| G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. Jiang F., Li P., Fornace A.J. Jr., Nicosia S.V., Bai W. J. Biol. Chem. 278:48030-48040(2003) · Mapped (2) |
| Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. Sun M., Yang L., Feldman R.I., Sun X.M., Bhalla K.N., Jove R., Nicosia S.V., Cheng J.Q. J. Biol. Chem. 278:42992-43000(2003) · Mapped (20) |
| AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. Yuan Z.Q., Feldman R.I., Sussman G.E., Coppola D., Nicosia S.V., Cheng J.Q. J. Biol. Chem. 278:23432-23440(2003) · UniProtKB (1) · Mapped (11) |
| Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Gritsko T.M., Coppola D., Paciga J.E., Yang L., Sun M., Shelley S.A., Fiorica J.V., Nicosia S.V., Cheng J.Q. Clin. Cancer Res. 9:1420-1426(2003) · Mapped (3) |
| Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial Cells. Yuan Z.Q., Feldman R.I., Sun M., Olashaw N.E., Coppola D., Sussman G.E., Shelley S.A., Nicosia S.V., Cheng J.Q. J. Biol. Chem. 277:29973-29982(2002) · Mapped (14) |
| Positive feedback regulation between Akt2 and MyoD during muscle differentiation. Cloning of Akt2 promoter. Kaneko S., Feldman R.I., Yu L., Wu Z., Gritsko T., Shelley S.A., Nicosia S.V., Nobori T., Cheng J.Q. J. Biol. Chem. 277:23230-23235(2002) · Mapped (8) |